Date published: 2026-4-24

1-800-457-3801

SCBT Portrait Logo
Seach Input

EGFR Inhibitor Inhibitor (CAS 879127-07-8)

5.0(1)
Write a reviewAsk a question

Alternate Names:
Cyclopropanecarboxylic acid-(3-(6-(3-trifluoromethyl-phenylamino)-pyrimidin-4-ylamino)-phenyl)-amide
Application:
EGFR Inhibitor is a highly selective, cell-permeable EGFR inhibitor
CAS Number:
879127-07-8
Molecular Weight:
413.4
Molecular Formula:
C21H18F3N5O
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

EGFR Inhibitor is a cell permeable compound that is a highly selective inhibitor of EGFR (epidermal growth factor receptor). Inhibition of EGFR may act to induce apoptosis. EGFR inhibition takes place via downregulation of antiapoptotic protein survivin expression. Downregulation of Survivin has been observed to take place following inhibition of the PI3K-AKT signaling pathway. Additional experiments report that EGFR inhibitor also induces upregulation of proapoptotic protein BIM.


EGFR Inhibitor Inhibitor (CAS 879127-07-8) References

  1. Discovery of EGFR selective 4,6-disubstituted pyrimidines from a combinatorial kinase-directed heterocycle library.  |  Zhang, Q., et al. 2006. J Am Chem Soc. 128: 2182-3. PMID: 16478150
  2. Amplification of EGFR T790M causes resistance to an irreversible EGFR inhibitor.  |  Ercan, D., et al. 2010. Oncogene. 29: 2346-56. PMID: 20118985
  3. Interdisciplinary management of EGFR-inhibitor-induced skin reactions: a German expert opinion.  |  Potthoff, K., et al. 2011. Ann Oncol. 22: 524-535. PMID: 20709812
  4. c-Met, epidermal growth factor receptor, and insulin-like growth factor-1 receptor are important for growth in uveal melanoma and independently contribute to migration and metastatic potential.  |  Wu, X., et al. 2012. Melanoma Res. 22: 123-32. PMID: 22343486
  5. Overcoming resistance to EGFR inhibitor in head and neck cancer: a review of the literature.  |  Rabinowits, G. and Haddad, RI. 2012. Oral Oncol. 48: 1085-9. PMID: 22840785
  6. A potential peptide therapeutic derived from the juxtamembrane domain of the epidermal growth factor receptor.  |  Boran, AD., et al. 2012. PLoS One. 7: e49702. PMID: 23166750
  7. Conditional inactivation of TNFα-converting enzyme in chondrocytes results in an elongated growth plate and shorter long bones.  |  Saito, K., et al. 2013. PLoS One. 8: e54853. PMID: 23349978
  8. Evolution and clinical impact of co-occurring genetic alterations in advanced-stage EGFR-mutant lung cancers.  |  Blakely, CM., et al. 2017. Nat Genet. 49: 1693-1704. PMID: 29106415
  9. Peptide ligand-mediated endocytosis of nanoparticles to cancer cells: Cell receptor-binding- versus cell membrane-penetrating peptides.  |  Jo, E., et al. 2018. Biotechnol Bioeng. 115: 1437-1449. PMID: 29460954
  10. Proteomic Analysis Reveals Novel Mechanisms by Which Polychlorinated Biphenyls Compromise the Liver Promoting Diet-Induced Steatohepatitis.  |  Hardesty, JE., et al. 2019. J Proteome Res. 18: 1582-1594. PMID: 30807179
  11. Deficiency of the splicing factor RBM10 limits EGFR inhibitor response in EGFR-mutant lung cancer.  |  Nanjo, S., et al. 2022. J Clin Invest. 132: PMID: 35579943
  12. A New EGFR Inhibitor from Ficus benghalensis Exerted Potential Anti-Inflammatory Activity via Akt/PI3K Pathway Inhibition.  |  Alaaeldin, R., et al. 2022. Curr Issues Mol Biol. 44: 2967-2981. PMID: 35877429
  13. Application of Compositions Comprising a KRAS G12C Inhibitor and an EGFR Inhibitor for the Potential Treatment of Cancer.  |  Kargbo, RB. 2022. ACS Med Chem Lett. 13: 1400-1401. PMID: 36105335
  14. Genomic and biological study of fusion genes as resistance mechanisms to EGFR inhibitors.  |  Kobayashi, Y., et al. 2022. Nat Commun. 13: 5614. PMID: 36153311
  15. Fusion Gene Detection in Prostate Cancer Samples Enhances the Prediction of Prostate Cancer Clinical Outcomes from Radical Prostatectomy through Machine Learning in a Multi-Institutional Analysis.  |  Yu, YP., et al. 2023. Am J Pathol. 193: 392-403. PMID: 36681188

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

EGFR Inhibitor, 1 mg

sc-203934
1 mg
$219.00